Stockreport

Intellia +1% after Baird start at Outperform [Seeking Alpha]

Intellia Therapeutics, Inc.  (NTLA) 
Last intellia therapeutics, inc. earnings: 2/27 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.intelliatx.com/investor-overview
PDF Intellia +1% after Baird start at Outperform Intellia Therapeutics (NASDAQ: NTLA up 1% The firm's set its price target to $23, implying 47% upside from today's close. Se [Read more]